GACAT3
gene geneOn this page
Also known as lncRNA-AC130710
Summary
GACAT3 (gastric cancer associated transcript 3, HGNC:50847) is a long non-coding RNA gene on chromosome 2p24.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50847 |
| Approved symbol | GACAT3 |
| Name | gastric cancer associated transcript 3 |
| Location | 2p24.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | lncRNA-AC130710 |
| Ensembl gene | ENSG00000236289 |
| Ensembl biotype | lncRNA |
| OMIM | 616132 |
| Entrez | 104797537 |
| RNAcentral | URS00007E409E — lncRNA, 984 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 21 lncRNA
ENST00000426539, ENST00000442387, ENST00000651705, ENST00000651908, ENST00000651993, ENST00000652394, ENST00000652731, ENST00000667080, ENST00000777279, ENST00000777280, ENST00000777281, ENST00000777282, ENST00000777283, ENST00000777284, ENST00000777285, ENST00000777286, ENST00000777287, ENST00000777288, ENST00000777289, ENST00000777290, ENST00000777291
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000426539 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001603503 | 16050427 | 16050677 |
| ENSE00001641159 | 16085289 | 16085801 |
| ENSE00001706921 | 16073304 | 16073442 |
| ENSE00001799252 | 16080898 | 16081090 |
Expression profiles
Bgee: expression breadth broad, 92 present calls, max score 96.28.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0835 / max 16.1639, expressed in 19 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 19018 | 0.0835 | 19 |
Top tissues by expression
97 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar vermis | UBERON:0004720 | 96.28 | gold quality |
| quadriceps femoris | UBERON:0001377 | 94.46 | gold quality |
| thymus | UBERON:0002370 | 75.49 | silver quality |
| bone marrow | UBERON:0002371 | 74.12 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 71.94 | silver quality |
| spinal cord | UBERON:0002240 | 62.25 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 62.22 | gold quality |
| ganglionic eminence | UBERON:0004023 | 60.56 | gold quality |
| ventricular zone | UBERON:0003053 | 59.46 | silver quality |
| primary visual cortex | UBERON:0002436 | 58.58 | gold quality |
| sural nerve | UBERON:0015488 | 57.22 | silver quality |
| substantia nigra | UBERON:0002038 | 57.03 | gold quality |
| prefrontal cortex | UBERON:0000451 | 56.85 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 55.88 | gold quality |
| spleen | UBERON:0002106 | 54.01 | gold quality |
| heart left ventricle | UBERON:0002084 | 53.78 | gold quality |
| monocyte | CL:0000576 | 53.13 | gold quality |
| urinary bladder | UBERON:0001255 | 53.03 | silver quality |
| right adrenal gland | UBERON:0001233 | 52.79 | gold quality |
| frontal cortex | UBERON:0001870 | 51.48 | gold quality |
| adrenal tissue | UBERON:0018303 | 51.18 | gold quality |
| minor salivary gland | UBERON:0001830 | 51.13 | gold quality |
| liver | UBERON:0002107 | 50.82 | silver quality |
| Ammon’s horn | UBERON:0001954 | 50.65 | gold quality |
| blood | UBERON:0000178 | 50.64 | gold quality |
| left ovary | UBERON:0002119 | 50.50 | gold quality |
| adrenal gland | UBERON:0002369 | 50.45 | gold quality |
| ovary | UBERON:0000992 | 50.35 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 49.87 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 49.74 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.61 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- lncRNA-AC130710 may be a potential tumor marker for gastric cancer prognosis (PMID:24969565)
- Studies suggest that GACAT2 (long noncoding RNA HMlincRNA717) and GACAT3 (long noncoding RNA AC130710) may play crucial roles in the occurrence, development and diagnosis of gastric carcinoma. (PMID:25077925)
- as a downstream target of the IL6/STAT3 signaling, Long non-coding RNA GACAT3 promotes gastric cancer cell growth suggesting that GACAT3 is an inflammatory response gene and may be served as a valuable potential target for the treatment of gastric cancer. (PMID:27644247)
- GACAT3 promotes breast cancer malignancy by sponging miR-497, leading to the enhancement of its endogenous target CCND2. These results suggest that GACAT3/miR-497/CCND2 is a potential therapeutic target and biomarker for breast cancer (PMID:29945347)
- Study demonstrate that GACAT3 acts as a competing endogenous RNA of HMGA1. Its knockdown resulted in significantly decreased cell proliferation of gastric cancer cells, similar to the effect of an HMGA1 knockdown. (PMID:30098426)
- This study elucidated that GACAT3/miR-3127-5p/ELAVL1 signaling regulates glioma development and might be a promising therapeutic target. (PMID:30317610)
- Long noncoding RNA GACAT3 regulates the expression of NAMPT to promote glioma progression by sponging miR-135a. (PMID:30536379)
- High LncRNA-GACAT3 expression is associated with breast cancer. (PMID:31983109)
- LncRNAs GACAT3 and LINC00152 regulate each other through miR-103 and are associated with clinicopathological characteristics in colorectal cancer. (PMID:32462718)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.